Integrated Biopharma (INBP) Income from Continuing Operations (2010 - 2026)
Integrated Biopharma (INBP) posted Income from Continuing Operations of -$1.37 million for fiscal Q4 2026 (quarter ended Jun 30, 2026), compared with -$178,000 a year earlier.
Powered by 
Analysis
Integrated Biopharma (INBP) Income from Continuing Operations (2010 - 2026) Analysis & Trends
For FY2026 (ended Jun 30, 2026), Integrated Biopharma's Income from Continuing Operations came in at -$2.84 million.
- In prior fiscal years, Integrated Biopharma's Income from Continuing Operations was $808,000 in FY2025 (+621.4%), $112,000 in FY2024, -$34,000 in FY2023 and $3.84 million in FY2022 (-52.1%).
- The fiscal Q4 2026 figure stands as the lowest quarterly Income from Continuing Operations since fiscal Q4 2012.
- The strongest year-over-year quarter for Income from Continuing Operations in the past five years was fiscal Q4 2024, with growth of 570.0%; the weakest was fiscal Q3 2023, with a decline of 98.0%.
- According to Business Quant data, Income from Continuing Operations for the three prior fiscal quarters was -$837,000 (Q3 2026), -$762,000 (Q2 2026) and $123,000 (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Procter & Gamble | 336.76 Bn | 292.75 Bn | 10.28 Bn | 3.08 Bn |
| 2 | Colgate Palmolive | 67.18 Bn | 62.24 Bn | 3.30 Bn | 719.00 Mn |
| 3 | Estee Lauder Companies | 33.32 Bn | 21.40 Bn | 2.74 Bn | -116.00 Mn |
| 4 | Kenvue | 33.09 Bn | 28.70 Bn | 2.30 Bn | 456.00 Mn |
| 5 | Kimberly Clark | 31.38 Bn | 28.71 Bn | 1.60 Bn | 410.00 Mn |
| 6 | Church & Dwight | 22.37 Bn | 20.90 Bn | 693.90 Mn | 202.80 Mn |
| 7 | Clorox | 9.72 Bn | 8.16 Bn | 804.00 Mn | 167.00 Mn |
| 8 | e.l.f. Beauty | 6.17 Bn | 5.15 Bn | 398.84 Mn | 66.60 Mn |
| 9 | Reynolds Consumer Products | 4.71 Bn | 4.37 Bn | 245.00 Mn | 138.00 Mn |
| 10 | Integrated Biopharma | 5.59 Mn | -14.75 Mn | 28,000.00 | -1.37 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.37 Mn |
| Mar 31, 2026 | -837,000.00 |
| Dec 31, 2025 | -762,000.00 |
| Sep 30, 2025 | 123,000.00 |
| Jun 30, 2025 | -178,000.00 |
| Mar 31, 2025 | 611,000.00 |
| Dec 31, 2024 | 116,000.00 |
| Sep 30, 2024 | 259,000.00 |
| Jun 30, 2024 | 268,000.00 |
| Mar 31, 2024 | 285,000.00 |
| Dec 31, 2023 | -382,000.00 |
| Sep 30, 2023 | -59,000.00 |
| Jun 30, 2023 | 40,000.00 |
| Mar 31, 2023 | 16,000.00 |
| Dec 31, 2022 | -55,000.00 |
| Sep 30, 2022 | -35,000.00 |
| Jun 30, 2022 | 1.49 Mn |
| Mar 31, 2022 | 797,000.00 |
| Dec 31, 2021 | 1.03 Mn |
| Sep 30, 2021 | 516,000.00 |
API Access
Integrated Biopharma Income from Continuing Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=INBP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-continuing-operations", "ticker": "INBP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=INBP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();